216 related articles for article (PubMed ID: 6305486)
21. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow cells: the source of hepatocellular carcinoma?
Wu XZ; Yu XH
Med Hypotheses; 2007; 69(1):36-42. PubMed ID: 17300877
[TBL] [Abstract][Full Text] [Related]
23. [Spectrum of antineoplastic agents in ascites hepatoma--hypothesis on application of the results of animal experiments to human cancer in screening of antineoplastic agents].
Sato H; Ichimura H
Nihon Rinsho; 1971 Jul; 29(7):1818-26. PubMed ID: 4338289
[No Abstract] [Full Text] [Related]
24. [Recent development in cancer chemotherapy].
Zhonghua Yi Xue Za Zhi; 1973; 8():499-508. PubMed ID: 4200752
[No Abstract] [Full Text] [Related]
25. Influence of methotrexate on purine and pyrimidine pools and on cell phase distribution of cultured human lymphoblasts.
De Abreu RA; Bökkerink JP; Bakker MA; Hulscher TW; van Baal JM; de Bruijn CH; Schretlen ED
Adv Exp Med Biol; 1986; 195 Pt B():105-11. PubMed ID: 3766227
[No Abstract] [Full Text] [Related]
26. Several new targets of antitumor agents.
Wang XW; Xu B
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):289-92. PubMed ID: 10072906
[TBL] [Abstract][Full Text] [Related]
27. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
28. Drug resistance: genotype versus phenotype--thirty-second G. H. A. Clowes Memorial Award Lecture.
Biedler JL
Cancer Res; 1994 Feb; 54(3):666-78. PubMed ID: 8306328
[No Abstract] [Full Text] [Related]
29. [Current pharmacotherapy of neoplastic diseases. II].
Witkowska M
Wiad Lek; 1969 Jul; 22(14):1307-13. PubMed ID: 5344011
[No Abstract] [Full Text] [Related]
30. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
[TBL] [Abstract][Full Text] [Related]
31. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular cancer, transplantation, and sirolimus.
Wall WJ
Liver Transpl; 2004 Oct; 10(10):1312-4. PubMed ID: 15376337
[No Abstract] [Full Text] [Related]
33. Modulation of cancer pathways by inhibitors of guanylate metabolism.
Oláh E; Kökény S; Papp J; Bozsik A; Keszei M
Adv Enzyme Regul; 2006; 46():176-90. PubMed ID: 16857242
[No Abstract] [Full Text] [Related]
34. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY
Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500
[TBL] [Abstract][Full Text] [Related]
35. [Role of oxidative stress in gene expression: myocardial and cerebral ischemia, cancer and other diseases].
Roche E; Romero-Alvira D
Med Clin (Barc); 1995 Apr; 104(12):468-76. PubMed ID: 7739286
[No Abstract] [Full Text] [Related]
36. Can maitake MD-fraction aid cancer patients?
Kodama N; Komuta K; Nanba H
Altern Med Rev; 2002 Jun; 7(3):236-9. PubMed ID: 12126464
[TBL] [Abstract][Full Text] [Related]
37. Irregular regeneration of hepatocytes and development of hepatocellular carcinoma in primary biliary cirrhosis.
Miyakawa H; Fujikawa H; Kikuchi K; Kitazawa E; Kawashima Y
Am J Gastroenterol; 2002 Feb; 97(2):488. PubMed ID: 11866295
[No Abstract] [Full Text] [Related]
38. [Endoscopic preventive metabolic hemo- and homeostasis in the treatment of ulcerous gastroduodenal bleedings complicated with a severe blood loss and hemorrhagic shock].
Timen LIa; Trubitsina IE; Chikunova BZ; Shertsinger A G ; Stongin SV; Zhigalova SB; Vasil'eva AA; Martynova IuV
Eksp Klin Gastroenterol; 2004; (3):50-3. PubMed ID: 15560402
[No Abstract] [Full Text] [Related]
39. A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells.
Jiang C; Zhou B; Fan K; Heung E; Xue L; Liu X; Kirschbaum M; Yen Y
Anticancer Res; 2007; 27(6B):3783-9. PubMed ID: 18225533
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?
Yamashita T
J Gastroenterol; 2004; 39(4):404-6. PubMed ID: 15168258
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
